On the 8th, HUGEL announced that it has formed a strategic partnership with the Brazilian aesthetic corporation Dermadream. The two companies plan to collaborate on sales, marketing, and education to target the Brazilian market.
HUGEL held a pre-launch event for the botulinum toxin product "Retivo" in Rio de Janeiro and São Paulo from the 4th to the 5th. The event introduced the product and shared application know-how and the latest clinical data.
At the Rio de Janeiro event, dermatologists attended, while dentists and biotechnology experts participated in São Paulo. A HUGEL official noted, "We will establish ourselves as a trusted toxin brand among Brazilian consumers and professionals."
※ This article has been translated by AI. Share your feedback here.